Global Health Limited · NSE: MEDANTA · BSE: 543654

Global Health

Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 30 Jul 2026.

Q1 FY27 · Consolidated

Revenue
1,304.05₹ Cr
+26.5% vs year ago
Net profit
157.25₹ Cr
−1.1% vs year ago
EPS, basic
5.91₹
−0.2% vs year ago
Net margin
12.1%
−3.4 pts vs year ago
Revenue₹ crore · consolidated · last 12 quarters
Q2 FY24: ₹843.94 CrQ3 FY24: ₹832.60 CrQ4 FY24: ₹808.63 CrQ1 FY25: ₹861.08 CrQ2 FY25: ₹956.55 CrQ3 FY25: ₹943.44 CrQ4 FY25: ₹931.25 CrQ1 FY26: ₹1,030.84 CrQ2 FY26: ₹1,099.22 CrQ3 FY26: ₹1,121.05 CrQ4 FY26: ₹1,159.05 CrQ1 FY27: ₹1,304.05 CrQ3 ’24Q1 ’25Q3 ’25Q1 ’26Q3 ’26Q1 ’27
Net profit₹ crore · consolidated · last 12 quarters
Q2 FY24: ₹125.16 CrQ3 FY24: ₹123.54 CrQ4 FY24: ₹127.35 CrQ1 FY25: ₹106.26 CrQ2 FY25: ₹130.82 CrQ3 FY25: ₹142.86 CrQ4 FY25: ₹101.38 CrQ1 FY26: ₹158.98 CrQ2 FY26: ₹158.40 CrQ3 FY26: ₹95.03 CrQ4 FY26: ₹141.65 CrQ1 FY27: ₹157.25 CrQ3 ’24Q1 ’25Q3 ’25Q1 ’26Q3 ’26Q1 ’27

Quarter by quarter

Consolidated · ₹ crore
QuarterRevenueYoYNet profitYoYEPS (₹)Filed
Q1 FY27Apr–Jun 20261,304.05+26.5%157.25−1.1%5.9130 Jul 2026
Q4 FY26Jan–Mar 20261,159.05+24.5%141.65+39.7%5.3614 May 2026
Q3 FY26Oct–Dec 20251,121.05+18.8%95.03−33.5%3.5404 Feb 2026
Q2 FY26Jul–Sep 20251,099.22+14.9%158.40+21.1%5.8907 Nov 2025
Q1 FY26Apr–Jun 20251,030.84+19.7%158.98+49.6%5.9207 Aug 2025
Q4 FY25Jan–Mar 2025931.25+15.2%101.38−20.4%3.7715 May 2025
Q3 FY25Oct–Dec 2024943.44+13.3%142.86+15.6%5.3204 Feb 2025
Q2 FY25Jul–Sep 2024956.55+13.3%130.82+4.5%4.8714 Nov 2024
Q1 FY25Apr–Jun 2024861.08+11.4%106.26+4.2%3.9609 Aug 2024
Q4 FY24Jan–Mar 2024808.63+15.0%127.35+26.0%4.7418 May 2024
Q3 FY24Oct–Dec 2023832.60+19.9%123.54+53.3%4.6109 Feb 2024
Q2 FY24Jul–Sep 2023843.94—125.16—4.6622 Nov 2023
Q1 FY24Apr–Jun 2023773.04—102.01—3.8010 Aug 2023
Q4 FY23Jan–Mar 2023703.42—101.07—3.7727 May 2023
Q3 FY23Oct–Dec 2022694.32—80.61—3.0816 Feb 2023
Standalone results
Standalone · ₹ crore
QuarterRevenueYoYNet profitYoYEPS (₹)Filed
Q1 FY27Apr–Jun 20261,078.72+22.3%137.31−9.6%5.1130 Jul 2026
Q4 FY26Jan–Mar 2026960.63+19.6%124.13+32.9%4.6214 May 2026
Q3 FY26Oct–Dec 2025940.16+50.6%79.91−19.5%2.9704 Feb 2026
Q2 FY26Jul–Sep 2025926.43+39.4%140.20+34.2%5.2207 Nov 2025
Q1 FY26Apr–Jun 2025882.16+44.3%151.96+57.8%5.6607 Aug 2025
Q4 FY25Jan–Mar 2025802.87+38.7%93.41+1.3%3.4815 May 2025
Q3 FY25Oct–Dec 2024624.40+11.2%99.31+13.7%3.7004 Feb 2025
Q2 FY25Jul–Sep 2024664.61+14.6%104.47+9.9%3.8914 Nov 2024
Q1 FY25Apr–Jun 2024611.45+12.3%96.28+11.7%3.5809 Aug 2024
Q4 FY24Jan–Mar 2024578.64+15.1%92.24+13.9%3.4318 May 2024
Q3 FY24Oct–Dec 2023561.68+14.7%87.34+48.6%3.2509 Feb 2024
Q2 FY24Jul–Sep 2023580.15—95.10—3.5422 Nov 2023
Q1 FY24Apr–Jun 2023544.59—86.21—3.2110 Aug 2023
Q4 FY23Jan–Mar 2023502.91—80.96—3.0227 May 2023
Q3 FY23Oct–Dec 2022489.79—58.77—2.2516 Feb 2023

30 filings on record for this company.